Mild-to-Moderate COVID-19 Infection and Myocarditis: A Review

被引:0
|
作者
Bailey, Eric [1 ]
Frishman, William H. H. [2 ,3 ]
机构
[1] New York Univ, Grossman Sch Med, Dept Med, New York, NY USA
[2] New York Med Coll, Westchester Med Ctr, Dept Med & Cardiol, Valhalla, NY USA
[3] New York Med Coll, Dept Med, 40 Sunshine Cottage Rd, Valhalla, NY 10595 USA
关键词
COVID-19; myocarditis; disease severity; SARS-COV-2; cardiomyopathy; EXPRESSION; ACE2;
D O I
10.1097/CRD.0000000000000458
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The coronavirus disease 2019 (COVID-19) pandemic has taken a massive toll on healthcare systems internationally. Severe illness has been seen in a range of patient populations, but those living with cardiovascular disease have suffered to a greater extent, likely because of their comorbidities. In patients with diabetes, hypertension, heart failure, and other chronic illnesses, COVID-19 has manifested severe illnesses such as coagulopathies, myocarditis, and arrhythmias, complicating the disease course for those already suffering from underlying illness. There have been numerous studies done exploring the cardiovascular complications of COVID-19. Some of the more concerning findings have revealed a correlation between severe illness and the increasing likelihood for developing cardiovascular manifestations. However, what is more concerning were the studies revealing the presence of myocarditis and other cardiac sequelae in previously healthy patients with mild or asymptomatic COVID-19. The goal of this article is to review the literature to compile information available about whether there is a significant risk of myocarditis in those patients who do not develop severe initial COVID-19 disease.
引用
收藏
页码:173 / 175
页数:3
相关论文
共 50 条
  • [11] Combined Metabolic Activators Accelerates Recovery in Mild-to-Moderate COVID-19
    Altay, Ozlem
    Arif, Muhammad
    Li, Xiangyu
    Yang, Hong
    Aydin, Mehtap
    Alkurt, Gizem
    Kim, Woonghee
    Akyol, Dogukan
    Zhang, Cheng
    Dinler-Doganay, Gizem
    Turkez, Hasan
    Shoaie, Saeed
    Nielsen, Jens
    Boren, Jan
    Olmuscelik, Oktay
    Doganay, Levent
    Uhlen, Mathias
    Mardinoglu, Adil
    [J]. ADVANCED SCIENCE, 2021, 8 (17)
  • [12] Distinguishing Incubation and Acute Disease Stages of Mild-to-Moderate COVID-19
    Mueller, Michael
    Volzke, Johann
    Subin, Behnam
    Schmidt, Christian Johann
    Geerdes-Fenge, Hilte
    Reisinger, Emil Christian
    Mueller-Hilke, Brigitte
    [J]. VIRUSES-BASEL, 2022, 14 (02):
  • [13] Critical review and analysis of approval of favipiravir for restricted emergency use in mild-to-moderate COVID-19
    Radhakrishnan, Arunkumar
    Arunachalam, Ruckmani
    Elango, Abinaya
    [J]. JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2020, 11 (01) : 1 - 7
  • [14] Focal Myocarditis after Mild COVID-19 Infection in Athletes
    Nedeljkovic, Ivana P.
    Giga, Vojislav
    Ostojic, Marina
    Djordjevic-Dikic, Ana
    Stojmenovic, Tamara
    Nikolic, Ivan
    Dikic, Nenad
    Nedeljkovic-Arsenovic, Olga
    Maksimovic, Ruzica
    Dobric, Milan
    Mujovic, Nebojsa
    Beleslin, Branko
    [J]. DIAGNOSTICS, 2021, 11 (08)
  • [15] Influence Of Physical Activity On Autonomic Function After Mild-to-moderate Covid-19 Infection In Young Adults
    Amin, Shaan N.
    Lira, Fabio S.
    Morano, Ana E. V. A.
    Pereira, Telmo
    Coelho-e-Silva, Manuel-Joao
    Caseiro, Armando
    Christofaro, Diego G. D.
    Ribeiro-Santos, Vanessa
    Marchioto Junior, Osmar
    Pinho, Ricardo A.
    Silva, Bruna S. D. A.
    Freire, Ana P. C. F.
    [J]. MEDICINE & SCIENCE IN SPORTS & EXERCISE, 2023, 55 (09) : 589 - 589
  • [16] DIAPHRAGMATIC STRENGTHENING EXERCISES FOR PATIENTS WITH POST COVID-19 CONDITION AFTER MILD-TO-MODERATE ACUTE COVID-19 INFECTION: A RANDOMIZED CONTROLLED STUDY
    Abo Elyazed, Tamer I.
    Abd El Moneim Abd El Hakim, Ahmed
    Saleh, Ola I.
    Mostafa Fadel Sonbol, Marwa
    Eid, Hoda Assad
    Moazen, Eman M.
    Alhassoon, Mohammad Hamad
    Ezzat Fathy Elfeky, Seham
    [J]. JOURNAL OF REHABILITATION MEDICINE, 2024, 56
  • [17] Tocilizumab, netakimab, and baricitinib in patients with mild-to-moderate COVID-19: An observational study
    Bryushkova, Ekaterina A.
    Skatova, Valeria D.
    Mutovina, Zinaida Y.
    Zagrebneva, Alena, I
    Fomina, Daria S.
    Kruglova, Tatyana S.
    Akopyan, Anna A.
    Strazhesko, Irina D.
    Lukyanov, Sergey A.
    Tkacheva, Olga N.
    Lysenko, Maryana A.
    Chudakov, Dmitry M.
    [J]. PLOS ONE, 2022, 17 (08):
  • [18] Mild or Moderate Covid-19
    Gandhi, Rajesh T.
    Lynch, John B.
    del Rio, Carlos
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (18): : 1757 - 1766
  • [19] Regional moderate hyperthermia for mild-to-moderate COVID-19 (TherMoCoV study): a randomized controlled trial
    Mancilla-Galindo, Javier
    Kammar-Garcia, Ashuin
    Mendoza-Gertrudis, Maria de Lourdes
    Garcia Acosta, Javier Michael
    Nava Serrano, Yanira Saralee
    Santiago, Oscar
    Torres Vasquez, Miriam Berenice
    Martinez Martinez, Daniela
    Fernandez-Urrutia, Liliana Aline
    Robledo Pascual, Julio Cesar
    Narvaez Morales, Ivan Daniel
    Velasco-Medina, Andrea Aida
    Mancilla-Ramirez, Javier
    Figueroa-Damian, Ricardo
    Galindo-Sevilla, Norma
    [J]. FRONTIERS IN MEDICINE, 2023, 10
  • [20] ARE MILD COVID-19 SYMPTOMS REALLY BENIGN? IDENTIFICATION OF SUBCLINICAL MYOCARDITIS IN A TEEN WITH REMOTE, MILD COVID-19 INFECTION
    Rye-Buckingham, Summer
    Bhimani, Salima
    Gupta, Dipankar
    Co-Vu, Jennifer
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 2369 - 2369